Merck’s MRK stock has declined around 10.3% in the past three months, losing almost $32 billion of its market value. Merck ...

The list price of Zepatier had been $54,600 for a course of treatment, lower than its competitors. The drug had $1.6 billion in sales in 2017. Other Merck drugs, which the company hasn't yet named ...

Merck's Keytruda scored two important victories in women's cancer, according to presentations Sunday at the ESMO meeting.

Merck (NYSE: MRK) stock has been a longtime winner for investors, returning 72% in the past five years. A major factor in ...

In this photo illustration, the Merck & Co., Inc. logo seen displayed on a ... [+] tablet. (Photo Illustration by Igor ...

Merck (NYSE:MRK) announced Wednesday that the U.S. Food and Drug Administration (FDA) approved a label expansion for its ...

默克Calbiochem 作为全球著名的信号转导类产品的供应商，专注于向客户提供全套的信号转导研究解决方案，产品涵盖信号转导研究的各个环节，针对PI3K-Akt-mTOR通路的特定靶分子我们可以提供与之对应的试剂盒、抑制剂、蛋白及底物、抗体，您还可以通过互动式mTOR ...

Merck (NYSE: MRK) is a top pharmaceutical company coming off a good quarter that shows it is growing its top and bottom lines. Even with that growth, the stock still trades at a fairly modest ...

The clinical study will evaluate MRK's experimental antibody treatment in patients with diabetic macular edema, a major cause ...

We recently compiled a list of the 10 Best Cancer Stocks To Buy Now ... It generates revenue mainly from pharmaceutical products and vaccines, with a significant portion coming from its cancer drug ...

Alteogen overtakes EcoPro BM, South Korea’s largest producer of cathodes for EV batteries, to become the biggest company on the Kosdaq by market capitalization.

We recently compiled a list of the 7 Best Stocks for Beginners with Little Money According ... The FDA’s late March approval of pulmonary arterial hypertension drug sotatercept, also drove share gains ...